A Prospective Study of Sexual Function in Men Taking Dutasteride for the Treatment of Androgenetic Alopecia
Phase of Trial: Phase III
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Dutasteride (Primary)
- Indications Alopecia
- Focus Adverse reactions; Registrational
- Sponsors Stiefel Laboratories
- 20 Jul 2016 Status changed from active, no longer recruiting to completed.
- 13 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Jul 2016.
- 13 Jun 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Jul 2016.